1-7 of 7
Natalie Galanina
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab

Raphael Steiner, Allison M. Bock, Alex F. Herrera, Omer Zulfa, Marc Hoffmann, Sami Ibrahimi, Natalie Galanina, Hun Ju Lee, Michael Green, Ruitao Lin, Chelsea C. Pinnix, Alison Moskowitz, Joachim Yahalom, Dai Chihara
Journal: Blood
Blood (2024) 144 (Supplement 1): 4434.2.
https://doi.org/10.1182/blood-2024-202516
Published: 2024
Journal Articles

Genomic Sequencing Reveals Complex and Actionable Molecular Profiles across Hematologic Malignancies

Natalie Galanina, MD, Catriona Jamieson, MD PhD, Razelle Kurzrock, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5116.
https://doi.org/10.1182/blood-2018-99-119877
Published: 2018
Journal Articles

Clonal Evolution Pattern of Leukemia Progression and Richter Transformation in Ibrutinib-Relapsed CLL Patients

Sabah Kadri, PhD, Jimmy Lee, MD, Carrie Fitzpatrick, PhD DABMG, Natalie Galanina, MD, Madina Sukhanova, PhD, Girish Venkataraman, MD MBBS, Shruti Sharma, PhD, Bradley Long, Megan Theissen, Mei Ming, PhD, Yuri Kobzev, Kang Wenjun, Ailin Guo, PhD MD, Weige V Wang, MD, Nifang Niu, PhD, Howie Lawrence Weiner, Michael J. Thirman, MD, Sonali M. Smith, MD, Jeremy P. Segal, MD PhD, Pin Lu, PhD, Y. Lynn Wang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3961.
https://doi.org/10.1182/blood.V128.22.3961.3961
Published: 2016
Journal Articles

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Natalie Galanina, MD, Sonali M. Smith, MD, Chuanhong Liao, PhD, Adam M. Petrich, MD, Bernadette Libao, Ron Gartenhaus, MD, Jason R Westin, MD, Kenneth S. Cohen, MD, James Knost, MD, Walter Stadler, MD, Austin Doyle, MD, Theodore Karrison, PhD, Leo I. Gordon, MD, Andrew M Evens, DO, MS
Journal: Blood
Blood (2015) 126 (23): 3990.
https://doi.org/10.1182/blood.V126.23.3990.3990
Published: 2015
Journal Articles

Risk Factors for CNS Relapse Among Patients with DLBCL Treated with EPOCH-R

Mary Kathryn Malecek, MD, Shaina Rozell, MD, Benjamin A. Chu, Trifilio Steve, Pharm D, Natalie Galanina, MD, Chadi Nabhan, MD, Adam M. Petrich, MD
Journal: Blood
Blood (2015) 126 (23): 1500.
https://doi.org/10.1182/blood.V126.23.1500.1500
Published: 2015
Journal Articles

Higher BTK-Dependent Cell Proliferation in Unmutated Chronic Lymphocytic Leukemia Confers Increased Sensitivity to Ibrutinib

Ailin Guo, PhDMD, Pin Lu, PhD, Natalie Galanina, MD, Chadi Nabhan, MD, Sonali M. Smith, MD, Morton Coleman, MD, Yue Lynn Wang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5296.
https://doi.org/10.1182/blood.V126.23.5296.5296
Published: 2015
Journal Articles

Patterns of Care of Aged Chronic Lymphocytic Leukemia Patients in the United States: Systematic Analysis of 457 Patients in the Connect CLL Registry

Chadi Nabhan, MD FACP, Natalie Galanina, MD, Neil E. Kay, MD, Anthony R. Mato, MD, David L. Grinblatt, MD, Thomas J. Kipps, MD, Nicole Lamanna, MD, Mark Weiss, MD, Ian Flinn, Arlene S. Swern, PhD, Thomas Street, Sullivan Kristen, MBA, Christopher R. Flowers, MD
Journal: Blood
Blood (2014) 124 (21): 4672.
https://doi.org/10.1182/blood.V124.21.4672.4672
Published: 2014